|
Saline (0.9% NaCl) Clinical Trials
2 actively recruiting trials across 1 location
▲ +1 trial since June 2026
Also known as: Placebo, dextrose
Pipeline
Phase 2: 1Phase 3: 1
Top Sponsors
- Pharmacosmos A/S1
- Affiliated Hospital of Nantong University1
Indications
- Coronary Arterial Disease (CAD)1
- Coronary Heart Disease1
- Heart Disease1
- Coronary Artery Disease1
- Limited Stage Small Cell Lung Cancer1
Other1 trial
Oakland, California1 trial
Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Pharmacosmos Investigational Site
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.